MacIntyre, I

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

Williams, B., MacDonald, T. M., Morant, S. V., Webb, D. J., Sever, P., McInnes, G. T., Ford, I., Cruickshank, J. K., Caulfield, M. J., Padmanabhan, S., et al. (2018) · The Lancet Diabetes & Endocrinology

Hormonal Regulation and HypertensionBlood Pressure and Hypertension Studies

Cited by 347

Long‐term adverse effects of paracetamol – a review

McCrae, J. C., Morrison, E. E., MacIntyre, I. M., Dear, J. W., & Webb, D. J. (2018) · British Journal of Clinical Pharmacology

Inflammatory mediators and NSAID effectsPharmaceutical Practices and Patient Outcomes

Cited by 308

CALCITONIN FOR PREVENTION OF POSTMENOPAUSAL BONE LOSS

Macintyre, I., Whitehead, M. I., Banks, L. M., Stevenson, J. C., Wimalawansa, S. J., & Healy, M. J. R. (1988) · The Lancet

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 204

Peptides from the calcitonin genes: molecular genetics, structure and function

Breimer, L. H., MacIntyre, I., & Zaidi, M. (1988) · Biochemical Journal

Neuropeptides and Animal PhysiologyParathyroid Disorders and Treatments

Cited by 189

The myotropic and plasma-calcium modulating effects of calcitonin gene-related peptide (CGRP)

Tippins, J. R., Morris, H. R., Panico, M., Etienne, T., Bevis, P., Girgis, S., MacIntyre, I., Azria, M., & Attinger, M. (1984) · Neuropeptides

Neuropeptides and Animal PhysiologyCardiovascular, Neuropeptides, and Oxidative Stress Research

Cited by 180

Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathways

Zaidi, M., Datta, H. K., Moonga, B. S., & MacIntyre, I. (1990) · Journal of Endocrinology

Bone Metabolism and DiseasesReceptor Mechanisms and Signaling

Cited by 150

THE MODE OF ACTION OF THYROCALCITONIN

Martin, T. J., Robinson, C. J., & Macintyre, I. (1966) · The Lancet

Thyroid Disorders and TreatmentsParathyroid Disorders and Treatments

Cited by 115

In vivo and in vitro effects of amylin and amylin-amide on calcium metabolism in the rat and rabbit

Datta, H. K., Zaidi, M., Wimalawansa, S. J., Ghatei, M. A., Beacham, J. L., Bloom, S. R., & MacIntyre, I. (1989) · Biochemical and Biophysical Research Communications

Bone Metabolism and DiseasesNeuropeptides and Animal Physiology

Cited by 114

Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial

MacIntyre, I. M., Turtle, E. J., Farrah, T. E., Graham, C., Dear, J. W., Webb, D. J., McCallum, M., Melville, V., Fok, H., McCrae, J. C., et al. (2022) · Circulation

Blood Pressure and Hypertension StudiesInflammatory mediators and NSAID effects

Cited by 80

Amylin‐amide: a new bone‐conserving peptide from the pancreas

Zaidi, M., Datta, H., Bevis, P., Wimalawansa, S., & MacIntyre, I. (1990) · Experimental Physiology

Bone Metabolism and DiseasesNeuropeptides and Animal Physiology

Cited by 61

AMYLINAMIDE, BONE CONSERVATION, AND PANCREATIC β CELLS

Macintyre, I. (1989) · The Lancet

Bone Metabolism and DiseasesPancreatic function and diabetes

Cited by 56

Diurnal Variation in Blood Pressure and Arterial Stiffness in Chronic Kidney Disease: The Role of Endothelin-1

Dhaun, N., Moorhouse, R., MacIntyre, I. M., Melville, V., Oosthuyzen, W., Kimmitt, R. A., Brown, K. E., Kennedy, E. D., Goddard, J., & Webb, D. J. (2014) · Hypertension

Cardiovascular Health and Disease PreventionBlood Pressure and Hypertension Studies

Cited by 54